A chemically defined 2,3- Trans procyanidin fraction from willow bark causes redox-sensitive endothelium-dependent relaxation in porcine coronary arteries

Journal of Natural Products

Volumn 77, Issue 7, 2014, Pages 1607-1614

  Kaufeld, Aurica M ^a   Pertz, Heinz H ^a   Kolodziej, Herbert ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2,3 TRANS PROCYANIDIN; BRADYKININ; CALCIUM CHANNEL; DICHLORODIHYDROFLUORESCEIN DIACETATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM CHANNEL; PROCYANIDIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BARK; CONTROLLED STUDY; CORONARY ARTERY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXPERIMENTAL PIG; FRACTIONATION; HOMEOSTASIS; HUMAN; HUMAN CELL; NONHUMAN; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASODILATATION; WESTERN BLOTTING; WILLOW;

ANIMALS; BIFLAVONOIDS; CATECHIN; CORONARY VESSELS; ENDOTHELIUM; FLUORESCEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MOLECULAR STRUCTURE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PLANT BARK; POLYPHENOLS; PROANTHOCYANIDINS; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SALIX; SIGNAL TRANSDUCTION; SWINE; VASODILATION;

EID: 84905055093     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np500177u     Document Type: Article

References (40)

1. Hedner, T.; Everts, B. Clin. Rheumatol. 1998, 17, 17-25
2. Nahrstedt, A.; Schmidt, M.; Jaggi, R.; Metz, J.; Khayyal, M. T. Wien. Med. Wochenschr. 2007, 157, 348-351
3. Schmid, B.; Kötter, I.; Heide, L. Eur. J. Clin. Pharmacol. 2001, 57, 387-391
4. Meier, B.; Julkunen-Tiitto, R.; Tahvanainen, J.; Sticher, O. J. Chromatogr. A 1988, 442, 175-186
5. Kammerer, B.; Kahlich, R.; Biegert, C.; Gleiter, C. H.; Heide, L. Phytochem. Anal. 2005, 16, 470-478
6. Kolodziej, H. Phytochemistry 1990, 29, 955-960
7. Kolodziej, H. J. Chem. Soc., Perkin Trans. 1 1988, 2, 219-226
8. Rasmussen, S. E.; Frederiksen, H.; Struntze Krogholm, K.; Poulsen, L. Mol. Nutr. Food Res. 2005, 49, 159-174
9. Manach, C.; Mazur, A.; Scalbert, A. Curr. Opin. Lipidol. 2005, 16, 77-84
10. Kaufeld, A. M.; Pertz, H. H.; Kolodziej, H. J. Agric. Food Chem. 2013, 61, 9609-9616
11. Matsuura, E.; Kobayashi, K.; Tabuchi, M.; Lopez, L. R. Prog. Lipid Res. 2006, 45, 466-486
12. Sawamura, T.; Kume, N.; Aoyama, T.; Moriwaki, H.; Hoshikawa, H.; Aiba, Y.; Tanaka, T.; Miwa, S.; Katsura, Y.; Kita, T. Nature 1997, 38, 73-77
13. Nishizuka, T.; Fujita, Y.; Yuko, S.; Nakano, A.; Kakino, A.; Ohshima, S.; Kanda, T.; Yoshimoto, R.; Sawamura, T. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2011, 87, 104-113
14. Stoclet, J.-C.; Chataigneau, T.; Ndiaye, M.; Oak, M.-H.; El Bedoui, J.; Chataigneau, M.; Schini-Kerth, V. B. Eur. J. Pharmacol. 2004, 500, 299-313
15. Schini-Kerth, V. B.; Auger, C.; Kim, J.-H.; étienne-Selloum, N.; Chataigneau, T. Pflügers Arch. 2010, 459, 853-862
16. Michel, T.; Vanhoutte, P. M. Pflügers Arch. 2010, 459, 807-816
17. Dimmeler, S.; Fleming, I.; Fisslthaler, B.; Hermann, C.; Busse, R.; Zeiher, A. M. Nature 1999, 399, 601-605
18. Auger, C.; Kim, J. H.; Chabert, P.; Chaabi, M.; Anselm, E.; Lanciaux, X.; Lobstein, A.; Schini-Kerth, V. B. Biochem. Biophys. Res. Commun. 2010, 393, 162-167
19. Ndiaye, M.; Chataigneau, T.; Andriantsitohaina, R.; Stoclet, J.-C.; Schini-Kerth, V. B. Biochem. Biophys. Res. Commun. 2003, 310, 371-377
20. Turrens, J. F. Biosci. Rep. 1997, 17, 3-8
21. Anselm, E.; Socorro, V. F.; Dal-Ros, S.; Schott, C.; Bronner, C.; Schini-Kerth, V. B. J. Cardiovasc. Pharmacol. 2009, 53, 253-60
22. Thannickal, V. J.; Fanburg, B. L. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279, L1005-L1028
23. Garland, C. J.; Hiley, C. R.; Dora, K. A. Br. J. Pharmacol. 2011, 164, 839-852
24. Feletou, M.; Vanhoutte, P. Clin. Sci. 2009, 117, 139-155
25. Feletou, M.; Vanhoutte, P. M.; Weston, A. H.; Edwards, G. Br. J. Pharmacol. 2003, 140, 225
26. Luksha, L.; Agewall, S.; Kublickiene, K. Atherosclerosis 2009, 202, 330-344
27. Chen, G.; Suzuki, H.; Weston, A. H. Br. J. Pharmacol. 1988, 95, 1165-1174
28. Fan, J.; Walsh, K. B. Circ. Res. 1999, 84, 451-457
29. Eichler, I.; Wibawa, J.; Grgic, I.; Knorr, A.; Brakemeier, S.; Pries, A. R.; Hoyer, J.; Köhler, R. Br. J. Pharmacol. 2003, 138, 594-601
30. Feletou, M.; Vanhoutte, P. M. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1215-1225
31. Ignarro, L. J.; Cirino, G.; Casini, A.; Napoli, C. J. Cardiovasc. Pharmacol. 1999, 34, 879-886
32. Nelson, M. T.; Cheng, H.; Rubart, M.; Santana, L. F.; Bonev, A. D.; Knot, H. J.; Lederer, W. J. Science 1995, 270, 633-637
33. Maruyama, T.; Kanaji, T.; Nakade, S.; Kanno, T.; Mikoshiba, K. J. Biochem. 1997, 122, 498-505
34. Dobrydneva, Y.; Blackmore, P. Mol. Pharmacol. 2001, 60, 541-552
35. Cohen, R. A.; Weisbrod, R. M.; Gericke, M.; Yaghoubi, M.; Bierl, C.; Bolotina, V. M. Circ. Res. 1999, 84, 210-219
36. Cohen, R. A.; Zitnay, K. M.; Haudenschild, C. C.; Cunningham, L. D. Circ. Res. 1988, 63, 903-910
37. Simon, B. C.; Cunningham, L. D.; Cohen, R. A. J. Clin. Invest. 1990, 86, 75-79
38. Mulvany, M. J.; Aalkjaer, C. Physiol. Rev. 1990, 70, 921-961
39. Husain, S.; Andrews, N. P.; Mulcahy, D.; Panza, J. A.; Quyyumi, A. A. Circulation 1998, 97, 716-720
40. Taubert, D.; Berkels, R.; Grosser, N.; Schröder, H.; Gründemann, D.; Schömig, E. Br. J. Pharmacol. 2004, 143, 159-165